Explore
Validate
LearnABIN2869484
antibody from antibodies-online
Targeting: MAPK1
ERK, ERK2, MAPK2, p41mapk, PRKM1, PRKM2
Western blot
ELISAAntibody data
- Antibody Data
- Antigen structure
- References [4]
- Comments [0]
- Validations
- Western blot [1]
- Immunohistochemistry [1]
- Flow cytometry [1]
Submit
Validation data
Reference
Comment
Report error
- Product number
- ABIN2869484 - Provider product page
- Provider
- antibodies-online
- Product name
- anti-Mitogen-Activated Protein Kinase 1/3 (MAPK1/3) antibody
- Antibody type
- Monoclonal
- Description
- Ascitic fluid
- Reactivity
- Human, Mouse
- Host
- Mouse
- Isotype
- IgG
- Antibody clone number
- 3F8
- Vial size
- 100 μL
- Storage
- Maintain refrigerated at 2-8°C for up to 6 months. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles.
Submitted references Genetical genomic determinants of alcohol consumption in rats and humans.
Protein kinase Cdelta supports survival of MDA-MB-231 breast cancer cells by suppressing the ERK1/2 pathway.
Phosphorylation of the human leukemia inhibitory factor (LIF) receptor by mitogen-activated protein kinase and the regulation of LIF receptor function by heterologous receptor activation.
Heterogeneous expression of four MAP kinase isoforms in human tissues.
Tabakoff B, Saba L, Printz M, Flodman P, Hodgkinson C, Goldman D, Koob G, Richardson HN, Kechris K, Bell RL, Hübner N, Heinig M, Pravenec M, Mangion J, Legault L, Dongier M, Conigrave KM, Whitfield JB, Saunders J, Grant B, Hoffman PL, WHO/ISBRA Study on State and Trait Markers of Alcoholism.
BMC biology 2009 Oct 27;7:70
BMC biology 2009 Oct 27;7:70
Protein kinase Cdelta supports survival of MDA-MB-231 breast cancer cells by suppressing the ERK1/2 pathway.
Lønne GK, Masoumi KC, Lennartsson J, Larsson C
The Journal of biological chemistry 2009 Nov 27;284(48):33456-65
The Journal of biological chemistry 2009 Nov 27;284(48):33456-65
Phosphorylation of the human leukemia inhibitory factor (LIF) receptor by mitogen-activated protein kinase and the regulation of LIF receptor function by heterologous receptor activation.
Schiemann WP, Graves LM, Baumann H, Morella KK, Gearing DP, Nielsen MD, Krebs EG, Nathanson NM
Proceedings of the National Academy of Sciences of the United States of America 1995 Jun 6;92(12):5361-5
Proceedings of the National Academy of Sciences of the United States of America 1995 Jun 6;92(12):5361-5
Heterogeneous expression of four MAP kinase isoforms in human tissues.
Gonzalez FA, Raden DL, Rigby MR, Davis RJ
FEBS letters 1992 Jun 15;304(2-3):170-8
FEBS letters 1992 Jun 15;304(2-3):170-8
No comments: Submit comment
Supportive validation
- Submitted by
- antibodies-online (provider)
- Main image
- Experimental details
- WB
Supportive validation
- Submitted by
- antibodies-online (provider)
- Main image
- Experimental details
- IHC
Supportive validation
- Submitted by
- antibodies-online (provider)
- Main image
- Experimental details
- FACS
